Covered recipient · General Payments record
ROBERT HEIFETZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$269.24
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $201.74 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $49.99 | 3 |
| Novo Nordisk AS | $33.45 | 2 |
| Phathom Pharmaceuticals, Inc. | $21.36 | 1 |
| Sumitomo Pharma America, Inc. | $18.11 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.53 | 1 |
| ABBVIE INC. | $16.90 | 1 |
| PFIZER INC. | $15.71 | 1 |
| Lilly USA, LLC | $14.54 | 1 |
| Amgen Inc. | $14.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.90 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103900040 | CMS |
| Amgen Inc. | $14.15 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117576080 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.95 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101230461 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.30 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101230457 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.74 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101230507 | CMS |
| Lilly USA, LLC | $14.54 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355162 | CMS |
| Novartis Pharmaceuticals Corporation | $17.53 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086941623 | CMS |
| Novo Nordisk Inc | $17.37 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097774798 | CMS |
| Novo Nordisk Inc | $16.08 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096794431 | CMS |
| PFIZER INC. | $15.71 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131039559 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.36 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151071264 | CMS |
| Sumitomo Pharma America, Inc. | $18.11 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148863133 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.